Home / MissionIR Articles

MissionIR Articles

  • Radcom (RDCM) Presents at Rodman & Renshaw Conference

    RADCOM Ltd. (NASDAQ: RDCM) provides innovative service assurance and customer experience management solutions for leading telecom operators and communications service providers. The company specializes in solutions for next-generation mobile and fixed networks – including LTE,…

  • Quantum Materials (QTMM) Presents at Rodman & Renshaw Conference

    Quantum Materials Corp. (OTCBB: QTMM) develops and manufactures Quantum Dots and nanomaterials for use in display, lighting, medical and solar energy through its patented continuous-flow production process. Quantum Materials’ products are the foundation for technologically…

  • Pure Bioscience (PURE) Presents at Rodman & Renshaw Conference

    Pure Bioscience, Inc. (OTCQB: PURE) is focused on developing and commercializing its proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. Its technology platform is based on…

  • Pulmatrix (PULM) Presents at Rodman & Renshaw Conference

    Pulmatrix, Inc. (NASDAQ: PULM) is developing innovative inhaled therapies to address serious pulmonary disease using its clinically validated, proprietary iSPERSE technology. Leveraging the unique capabilities of iSPERSE to dramatically advance inhalation technology, the company means…

  • Protalex (PRTX) Presents at Rodman & Renshaw Conference

    Protalex, Inc. (OTCBB: PRTX) is a biotechnology company developing a new class of drugs with the potential to revolutionize the treatment of autoimmune and inflammatory diseases, including Rheumatoid Arthritis (RA) and Immune Thrombocytopenia (ITP). Protalex’s…

  • Prima BioMed (PBMD) Presents at Rodman & Renshaw Conference

    Prima BioMed Ltd. (NASDAQ: PBMD) is a globally active biotechnology company that is striving to become a leader in the development of immunotherapeutic products for the treatment of cancer. Prima BioMed is dedicated to leveraging…

  • Pretium Resources (PVG) Presents at Rodman & Renshaw Conference

    Pretium Resources, Inc. (NYSE: PVG) is advancing the high-grade gold Brucejack Project to production. The company is creating value through gold at its 100%-owned, advanced-stage Brucejack Project, which is located 65 kilometers north of the…

  • PolyMet Mining (PLM) Presents at Rodman & Renshaw Conference

    PolyMet Mining Corp. (NYSE: PLM) is a mine development company focused on permitting, building and operating the NorthMet copper-nickel-precious metals project through its wholly owned subsidiary, Poly Met Mining, Inc., a Minnesota corporation. Through long-term…

  • Pointer Telocation (PNTR) Presents at Rodman & Renshaw Conference

    Pointer Telocation Ltd. (NASDAQ: PNTR) is a leading provider of cutting-edge products and technology, and Software as a Service (SaaS) to the fleet, automotive, insurance, cargo and public-safety industries. Pointer Telocation has a growing client…

  • Plug Power (PLUG) Presents at Rodman & Renshaw Conference

    Plug Power, Inc. (NASDAQ: PLUG)aims to revolutionize the fuel cell industry with cost-effective solutions that increase productivity, lower operating costs and reduce carbon footprint. Its signature solution, GenKey, provides an all-inclusive package for customers, incorporating…

  • Pieris Pharmaceuticals (PIRS) Presents at Rodman & Renshaw Conference

    Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is a clinical-stage biotechnology company applying its proprietary Anticalin technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a…

  • Pershing Gold (PGLC) Presents at Rodman & Renshaw Conference

    Pershing Gold Corporation (OTCQB: PGLC) is an emerging Nevada gold producer uniquely positioned to create shareholder value by fast-track reopening of the Relief Canyon Mine. The company’s strategy to create shareholder value has four elements:…

  • Perseon (PRSN) Presents at Rodman & Renshaw Conference

    Perseon Corporation (NASDAQ: PRSN)is singularly focused on fighting one of humanity’s worst diseases, cancer, and on helping physicians and their patients fight cancer with technology. The company is dedicated to developing innovative technologies to fight…

  • Perma-Fix Environmental Services (PESI) Presents at Rodman & Renshaw Conference

    Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) is a nuclear services company and provider of nuclear and mixed waste management services. The company’s nuclear waste services include management and treatment of radioactive and mixed waste for…

  • PCM (PCMI) Presents at Rodman & Renshaw Conference

    Since 1987, PCM, Inc. (NASDAQ: PCMI) has provided IT products, services and solutions to businesses, government agencies, educational, institutions and healthcare facilities. The company provides access to more than 300,000 IT products like tablets, slate,…

  • EDAP TMS S.A (EDAP) Presents at Rodman & Renshaw Conference

    EDAP TMS S.A. (NASDAQ: EDAP) is a global leader in therapeutic ultrasound that has been present in the market for more than 35 years. The company develops, manufactures, promotes and distributes minimally-invasive medical devices for…

  • PAR Technology (PAR) Presents at Rodman & Renshaw Conference

    PAR Technology Corp. (NYSE: PAR)offers technology solutions for the full spectrum of restaurant operations, from large chain and independent table service restaurants to international quick service chains. PAR’s Hospitality business also markets hotel management systems…

  • OXIS International (OXIS) Presents at Rodman & Renshaw Conference

    OXIS International, Inc. (OTC: OXIS)develops innovative drugs focused on the treatment of cancer and other unmet medical needs.  OXIS’ lead drug candidate, DT2219ARL, is a novel bispecific scFv recombinant fusion protein-drug that simultaneously targets cancer…

  • OvaScience (OVAS) Presents at Rodman & Renshaw Conference

    OvaScience, Inc. (NASDAQ: OVAS) is a global fertility company; each OvaScience treatment is based on the company’s proprietary technology platform that leverages the breakthrough discovery of egg precursor (EggPCSM) cells – immature egg cells found…

  • OvaScience (OVAS) Presents at Rodman & Renshaw Conference

    OvaScience, Inc. (NASDAQ: OVAS) is a global life sciences company dedicated to improving fertility for women around the world. OvaScience is discovering, developing and commercializing new fertility treatments because it believes women deserve more options.…

  • Orient Paper (ONP) Presents at Rodman & Renshaw Conference

    Orient Paper, Inc. (NYSE: ONP) is a leading paper manufacturer in North China. Using recycled paper as its primary raw material (with the exception of its digital photo paper and tissue paper products), Orient Paper produces…

  • Oramed Pharmaceuticals (ORMP) Presents at Rodman & Renshaw Conference

    Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) was established in 2006, and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection. From the company’s inception, Oramed…

  • Opexa Therapeutics (OPXA) Presents at Rodman & Renshaw Conference

    Opexa Therapeutics, Inc. (NASDAQ: OPXA) is a biotechnology company developing personalized immunotherapies with the potential to treat major illnesses, including multiple sclerosis (MS) as well as other autoimmune diseases, such as neuromyelitisoptica (NMO). These therapies…

  • Oncothyreon (ONTY) Presents at Rodman & Renshaw Conference

    Oncothyreon, Inc. (NASDAQ: ONTY) is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients. Recognizing that cancer is a complex disease involving changes to…

  • OncoSec Medical (ONCS) Presents at Rodman & Renshaw Conference

    Established in 2011, OncoSec Medical Incorporated (NASDAQ: ONCS) is a San Diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. Through its proprietary technology, the company means…

  • Onconova Therapeutics (ONTX) Presents at Rodman & Renshaw Conference

    Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of…

  • Oculus Innovative Sciences (OCLS) Presents at Rodman & Renshaw Conference

    Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) has designed a humanitarian program to respond to unexpected disasters—floods, earthquakes, tsunamis, hurricanes, epidemics and even man-made calamities—by providing product (such as food or medical assistance) to these victims.…

  • Ocera Therapeutics (OCRX) Presents at Rodman & Renshaw Conference

    Ocera Therapeutics, Inc. (NASDAQ: OCRX) is a clinical stage biopharmaceutical companyfocused on the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease. Ocera’s lead program, OCR-002 (ornithine phenylacetate) is an…

  • Ocean Power Technologies (OPTT) Presents at Rodman & Renshaw Conference

    Ocean Power Technologies, Inc. (NASDAQ: OPTT) is a pioneer in renewable wave-energy technology that converts ocean wave energy into electricity. OPT’s proprietary PowerBuoy technology is based on a modular design and has undergone periodic ocean…

  • ENGlobal Corp. (ENG) Bolsters Management Team, Prepares for Market Growth

    Through its engineering and construction group, ENGlobal Corp. (NASDAQ: ENG) delivers innovative, cost-effective automation and specialty construction projects for customers around the world. Consistently included on Engineering News Record magazine’s annual list of the top…

  • Novatel Wireless (NVTL) Presents at Rodman & Renshaw Conference

    Novatel Wireless, Inc. (NASDAQ: NVTL) delivers intelligent wireless solutions that simplify the Internet of Things (IoT). The company has invented and reinvented ways in which the world stays connected and accesses information. With multiple first-to-market…

  • NovaBay Pharmaceuticals (NBY) Presents at Rodman & Renshaw Conference

    NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. NovaBay has two distinct product categories:…

  • Northwest Biotherapeutics (NWBO) Presents at Rodman & Renshaw Conference

    Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) is developing cancer vaccines designed to treat a broad range of solid tumor cancers more efficiently and cost-effectively than current treatments, and without the side effects of chemotherapy drugs. The…

  • Nivalis Therapeutics (NVLS) Presents at Rodman & Renshaw Conference

    Boulder, Colorado-based Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is discovering solutions for cystic fibrosis. The company is developing a class of disease-modifying therapies designed to preserve intracellular GSNO (S-nitrosoglutathione), an endogenous molecule with cell-signaling effects that…

  • NeuroMetrix (NURO) Presents at Rodman & Renshaw Conference

    NeuroMetrix, Inc. (NASDAQ: NURO) is an innovative health-care company developing wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases and sleep disorders. Established in 1996 by Shai…

  • NephroGenex (NRX) Presents at Rodman & Renshaw Conference

    NephroGenex, Inc. (NASDAQ: NRX) is an innovator in the development of drugs to treat kidney disease with a first indication in diabetic nephropathy. It has been pioneering the development of PYRIDORIN (pyridoxaminedihydrochloride), a late stage…

  • NanoViricides (NNVC) Presents at Rodman & Renshaw Conference

    NanoViricides, Inc. (NYSE: NNVC) is a development stage company with a unique nanomedicine technology. The company is developing nanotechnology-based biomimetic anti-viral medicines called “nanoviricides.” So far, virus-specific nanoviricide drug candidates against five commercially important viral…

  • Nano Dimension (NNDMY) Presents at Rodman & Renshaw Conference

    Nano Dimension (OTC: NNDMY) was founded in 2012 and focuses on the research and development of advanced 3D electronics printing, including a printer for printing PCBs (printed circuit boards), and the development of nanotechnology- based…

  • Cleveland BioLabs (CBLI) Presents at Rodman & Renshaw Conference

    Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company, is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of toll-like immune receptor activators has applications in radiation…

  • MicroVision (MVIS) Presents at Rodman & Renshaw Conference

    MicroVision, Inc. (NASDAQ: MVIS) is a world leader in the innovation of a new generation of display technology. The company opens up a world of possibilities by bringing enhanced visibility to the world of mobility.…